SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-14-071785
Filing Date
2014-10-15
Accepted
2014-10-15 16:15:36
Documents
11
Period of Report
2014-08-31

Document Format Files

Seq Description Document Type Size
1 10-Q a14-21588_110q.htm 10-Q 332332
2 EX-31.1 a14-21588_1ex31d1.htm EX-31.1 9401
3 EX-31.2 a14-21588_1ex31d2.htm EX-31.2 9371
4 EX-32.1 a14-21588_1ex32d1.htm EX-32.1 6075
5 EX-32.2 a14-21588_1ex32d2.htm EX-32.2 6054
  Complete submission text file 0001104659-14-071785.txt   1549892

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT bzyr-20140831.xml EX-101.INS 151940
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT bzyr-20140831.xsd EX-101.SCH 15924
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT bzyr-20140831_cal.xml EX-101.CAL 14442
9 XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT bzyr-20140831_lab.xml EX-101.LAB 135615
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT bzyr-20140831_pre.xml EX-101.PRE 83786
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT bzyr-20140831_def.xml EX-101.DEF 25874
Mailing Address
Business Address 12000 RICHMOND AVE HOUSTON TX 77082
BURZYNSKI RESEARCH INSTITUTE INC (Filer) CIK: 0000724445 (see all company filings)

IRS No.: 760136810 | State of Incorp.: DE | Fiscal Year End: 0228
Type: 10-Q | Act: 34 | File No.: 000-23425 | Film No.: 141157772
SIC: 2835 In Vitro & In Vivo Diagnostic Substances